Other articles:
|
Jun 6, 2011 . CHICAGO (Reuters) - Exelixis Inc's cabozantinib experimental drug shrank bone
Jul 22, 2011 . 81 Exelixis salary reports. A free inside look at Exelixis salaries posted
Nov 2, 2011 . Shares for drug maker Exelixis dropped Tuesday after the company announced it
Nov 7, 2011 . Exelixis (EXEL) saw its share price cut in half last week, due to a regulatory
Jun 6, 2011 . CHICAGO (Reuters) - Shares of Exelixis Inc fell 20 percent on Monday after the
Apr 12, 2011 . Exelixis Inc. is working with Goldman Sachs Group Inc. to prepare for potential
Our senior management team is committed to helping each member of the
US:EXEL - Get Stock quote detail for Exelixis Inc. Stock quotes include the latest
X-Ceptor was subsequently acquired by Exelixis Inc. in October 2004. Exelixis
Jun 6, 2011 . Exelixis, Inc. (NASDAQ:EXEL) reported longer follow-up data from a fully enrolled
Exelixis' detailed financials; Comprehensive pipeline breakdown, including
Nov 14, 2011 . Exelixis, Inc. today reported interim data on pain relief and related reduction in
Aug 22, 2011 . It is hard to be neutral on Exelixis' (EXEL) lead drug - people either love it or hate
7 hours ago . Lazard Capital downgraded Exelixis (NASDAQ: EXEL) from Buy to Hold. For an
Sep 16, 2011 . What: Shares of drug developer Exelixis (Nasdaq: EXEL ) traded down slowly on
Exelixis Inc. financial and business news, updates, and information from The
Under the terms of the collaboration, BMS agreed to pay Exelixis US$195 million
Company Overview: At Exelixis, our vision is to be a world-class commercial
Last month, Exelixis completed the acquisition of a small agricultural biotech
EXEL Stock Quote, and financial news from the leading provider and award-
Mar 8, 2010 . I'm hearing from more than one source that Exelixis has laid off about 40% of
Jul 7, 2011 . Exelixis Inc. will delay data from a final-stage trial of its lead experimental drug in
Lightning Round: Caterpillar, Exelixis, Photronics and More. Published: Friday,
Oct 24, 2011 . Exelixis Inc. (EXEL) reported positive results from a key late-stage trial of its
Jan 31, 2011 . These two development-stage biotechs join Dendreon and Johnson & Johnson
Apr 12, 2011 . Report says several parties have sniffed around following successful study of
1 day ago . See the company profile for Exelixis, Inc. (EXEL) including business summary,
1 day ago . This Is the Next Big Opportunity With Drug Stocks10 hours ago – The Motley Fool
Oct 27, 2011 . Exelixis' Cabozantinib Targets Particularly Sick Thyroid Cancer Patients - The
Exelixis, Inc. is a development-stage biotechnology company dedicated to the
Nov 1, 2011 . Exelixis ($EXEL) upset investors with news late yesterday that the developer
Read exclusive insider information and reviews on Exelixis Inc.. Get Exelixis
3 days ago . Exelixis, Inc. (NASDAQ:EXEL) will host its seventh annual R&D Day on Thursday,
Dec 17, 2010 . Stripped to its bare essentials and undertaking its second major layoff in less .
Welcome to the company profile of Exelixis on LinkedIn. At Exelixis, our vision is
Oct 20, 2010 . Mike Morrissey had plenty of headaches when he took over as CEO of South San
Genomics-based discovery company focused on development of drugs, crop
PLEASE NOTE: Since we can no longer use FedEx to ship to the following
1 day ago . Exelixis, Inc. (EXEL) Piper Jaffray Health Care Conference Call November 29,
Exelixis (EXEL) stock quote, charts, historical data, financials.
Nov 1, 2011 . Tallahassee, FL 11/1/11 (StreetBeat) --Exelixis Inc. Food and Drug Administration
4 days ago . {Businesswire via BioPortfolio} Exelixis, Inc. (Nasdaq: EXEL) today announced
Nov 3, 2011 . Exelixis, Inc. (EXEL) Special Conference Call October 31, 2011 6:00 PM ET .
Indiferent ca este vorba de resoftarea calculatorului standard al masinii sau de
Nov 3, 2011 . Exelixis Inc., a biotechnology company with no approved products, plunged the
Nov 1, 2011 . Exelixis faces a delay in reaching approval for its prostate cancer drug
View the basic EXEL stock chart on Yahoo! Finance. Change the date range,
Keep, share, and discover the best of the Web using Delicious, the world's
Share your videos with friends, family, and the world.
32 confirmed response rate per RECIST in patients with platinum-resistant or
Exelixis is a genomics-based drug discovery company located in South San
Sitemap
|